News & Updates
Showing Oncology articles
Showing

Neratinib plus trastuzumab effective in metastatic TNBC with HER2 mutations
Combining neratinib with trastuzumab is associated with longer duration of response and progression-free survival (PFS) vs neratinib alone in patients with HER2-mutant metastatic triple-negative breast cancer (TNBC), according to the results of the open-label phase II SUMMIT trial.

Higher dermatologist availability improves early-stage melanoma detection
Better access to dermatologic care enables earlier melanoma detection at the population level, suggests a US study, noting an association between greater dermatologist density and a lower proportion of melanoma cases diagnosed at a late stage.

Radiation proctitis and cystitis may emerge years after prostate cancer RT
Radiation cystitis (RC) and radiation proctitis (RP) are common complications of radiotherapy (RT) in patients with prostate cancer, each with a 10-year cumulative incidence of ≥20 percent, according to researchers from the Chinese University of Hong Kong.

Baseline NLR predicts risk of severe CIP in patients with NSCLC
A high neutrophil-to-lymphocyte ratio (NLR; ≥4.75) at baseline appears to contribute to an elevated risk of developing severe checkpoint inhibitor pneumonitis (CIP) in patients with nonsmall cell lung cancer (NSCLC), suggests a study.




